Nurix director granted 31,250 stock options
Nurix Therapeutics, Inc. director Judith A. Reinsdorf received a grant of stock options covering 31,250 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. director Judith A. Reinsdorf received a grant of stock options covering 31,250 shares of common stock. The options have an exercise price of $15.86 per share and expire on May 14, 2036. The entire award vests 100% on the earlier of the company’s next annual stockholder meeting or May 15, 2027, subject to her continued service, giving her 31,250 options beneficially owned after this grant.
Insider Trade Summary
Grant/Award: 31,250 shares
Grant/Award
1 txn
Insider
Reinsdorf Judith A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 31,250 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Option (right to buy) — 31,250 contracts (Direct)
Footnotes (1)
- F1. The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
Key Figures
Option grant size: 31,250 shares
Exercise price: $15.86 per share
Expiration date: May 14, 2036
+2 more
5 metrics
Option grant size
31,250 shares
Director stock option award underlying common stock
Exercise price
$15.86 per share
Director stock option exercise price
Expiration date
May 14, 2036
Option term end date
Vesting deadline
May 15, 2027
Latest possible 100% vesting date, subject to service
Post-transaction options held
31,250 options
Total derivative securities beneficially owned after grant
Key Terms
Director Stock Option (right to buy), exercise price, expiration date, vesting
4 terms
Director Stock Option (right to buy) financial
"security_title: Director Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 15.8600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-14T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Nurix Therapeutics (NRIX) director Judith Reinsdorf report on this Form 4?
Judith A. Reinsdorf reported receiving a grant of stock options for 31,250 shares of Nurix Therapeutics common stock. These options are a compensation award and do not reflect an open-market purchase or sale of existing shares.
What are the key terms of Judith Reinsdorf’s Nurix (NRIX) stock option grant?
The stock option covers 31,250 shares of Nurix common stock at an exercise price of $15.86 per share. It expires on May 14, 2036, giving a long-dated right to buy shares at that fixed price.
How do the Nurix (NRIX) options granted to Judith Reinsdorf vest?
The option vests 100% on the earlier of the next annual meeting of Nurix stockholders or May 15, 2027. Vesting is conditioned on her continued service to the company through the applicable vesting date.
How many Nurix (NRIX) options does Judith Reinsdorf hold after this transaction?
Following this transaction, she beneficially owns 31,250 stock options tied to Nurix common shares. This equals the full size of the reported grant, as this Form 4 does not list any prior option holdings.
What does the $15.86 exercise price mean for the Nurix (NRIX) option grant?
The $15.86 exercise price is the fixed price at which she may buy Nurix common stock when the option is exercised. If the stock trades above this price after vesting, the option could have intrinsic value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
